Moran Yang

573 total citations
15 papers, 369 citations indexed

About

Moran Yang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Moran Yang has authored 15 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Moran Yang's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (6 papers). Moran Yang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers) and Immune cells in cancer (6 papers). Moran Yang collaborates with scholars based in China and United States. Moran Yang's co-authors include Haiou Liu, Guodong Zhang, Mengdi He, Jiaqi Lu, Yiying Wang, Congjian Xu, Qing Xu, Xiangyun Zhang, Hongwei Zhang and Yan Huang and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Cancer Immunology Immunotherapy.

In The Last Decade

Moran Yang

13 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moran Yang China	10	232	189	107	67	57	15	369
Mengdi He China	9	222 1.0×	181 1.0×	92 0.9×	56 0.8×	53 0.9×	12	338
Sherman Lau Canada	5	124 0.5×	202 1.1×	83 0.8×	72 1.1×	54 0.9×	6	372
Jodi A. McKenzie United States	8	81 0.3×	121 0.6×	155 1.4×	54 0.8×	73 1.3×	30	302
Miseon Lee South Korea	7	172 0.7×	230 1.2×	51 0.5×	45 0.7×	46 0.8×	19	297
Marion Jacquin France	8	128 0.6×	161 0.9×	156 1.5×	68 1.0×	56 1.0×	16	340
Sho Sato Japan	12	101 0.4×	157 0.8×	117 1.1×	81 1.2×	67 1.2×	32	411
Chelsea Jin United States	4	261 1.1×	362 1.9×	113 1.1×	73 1.1×	73 1.3×	9	459
Perrine Garde‐Granger Canada	11	117 0.5×	166 0.9×	125 1.2×	52 0.8×	36 0.6×	12	349
Yuichi Imai Japan	10	84 0.4×	109 0.6×	136 1.3×	28 0.4×	28 0.5×	23	297
Qinbo Cai China	8	211 0.9×	217 1.1×	155 1.4×	88 1.3×	97 1.7×	17	461

Countries citing papers authored by Moran Yang

Since Specialization

Citations

This map shows the geographic impact of Moran Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moran Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moran Yang more than expected).

Fields of papers citing papers by Moran Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moran Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moran Yang. The network helps show where Moran Yang may publish in the future.

Co-authorship network of co-authors of Moran Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Moran Yang. A scholar is included among the top collaborators of Moran Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moran Yang. Moran Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Wang, Chenyang, Moran Yang, Yiying Wang, et al.. (2025). Immunosuppressive JAG2 ⁺ tumor‐associated neutrophils hamper PD‐1 blockade response in ovarian cancer by mediating the differentiation of effector regulatory T cells. Cancer Communications. 45(7). 747–773. 1 indexed citations

He, Mengdi, Chenyang Wang, Xueling Wang, et al.. (2025). Mannose Enhances Immunotherapy Efficacy in Ovarian Cancer by Modulating Gut Microbial Metabolites. Cancer Research. 85(13). 2468–2484. 3 indexed citations

Xu, Xuyao, et al.. (2025). Targeting mesothelin-CD24 axis repolarizes tumor-associated macrophages to potentiate PD-1 blockade therapy in high-grade serous ovarian cancer. Journal for ImmunoTherapy of Cancer. 13(2). e011230–e011230. 9 indexed citations

Zhao, Hui, Wei‐Syun Hu, Moran Yang, et al.. (2025). Carotid plaque CTA analysis in patients with initial and recurrent ischemic stroke. European Journal of Radiology. 186. 112058–112058.

Zhang, Guodong, Moran Yang, Mengdi He, et al.. (2023). Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer. Cancer Research. 83(13). 2171–2186. 23 indexed citations

Wang, Yiying, Mengdi He, Guodong Zhang, et al.. (2023). Siglec-9⁺ tumor-associated macrophages delineate an immunosuppressive subset with therapeutic vulnerability in patients with high-grade serous ovarian cancer. Journal for ImmunoTherapy of Cancer. 11(9). e007099–e007099. 12 indexed citations

Huang, Zixin, et al.. (2023). On the Calculation of Several Definite Integrals by Residue Theorem. Highlights in Science Engineering and Technology. 38. 317–322. 1 indexed citations

Yang, Moran, Yiying Wang, Mengdi He, et al.. (2023). C5aR1 blockade reshapes immunosuppressive tumor microenvironment and synergizes with immune checkpoint blockade therapy in high-grade serous ovarian cancer. OncoImmunology. 12(1). 2261242–2261242. 16 indexed citations

He, Mengdi, et al.. (2021). The immune landscape during the tumorigenesis of cervical cancer. Cancer Medicine. 10(7). 2380–2395. 25 indexed citations

10.

He, Mengdi, et al.. (2021). The prognostic significance of tumor-infiltrating lymphocytes in cervical cancer. Journal of Gynecologic Oncology. 32(3). e32–e32. 11 indexed citations

11.

Zhang, Guodong, Xiangyun Zhang, Moran Yang, et al.. (2021). Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response. OncoImmunology. 10(1). 1969075–1969075. 28 indexed citations

12.

Yang, Moran, Jiaqi Lu, Guodong Zhang, et al.. (2021). CXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer. Journal for ImmunoTherapy of Cancer. 9(1). e001136–e001136. 154 indexed citations

13.

Zhang, Guodong, Qing Xu, Xiangyun Zhang, et al.. (2021). Spatial cytotoxic and memory T cells in tumor predict superior survival outcomes in patients with high‐grade serous ovarian cancer. Cancer Medicine. 10(12). 3905–3918. 8 indexed citations

14.

Yang, Moran, Guodong Zhang, Yiying Wang, et al.. (2020). Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer. British Journal of Cancer. 123(9). 1404–1416. 55 indexed citations

15.

Zhang, Guodong, Jiaqi Lu, Moran Yang, et al.. (2019). Elevated GALNT10 expression identifies immunosuppressive microenvironment and dismal prognosis of patients with high grade serous ovarian cancer. Cancer Immunology Immunotherapy. 69(2). 175–187. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact